SCHEDULE: ReShape Lifesciences: Key Investor Exits Stake

CVI Investments and Heights Capital Management report 0% beneficial ownership in ReShape Lifesciences Inc., indicating a full divestment.

Summary

• CVI Investments, Inc. and Heights Capital Management, Inc. (Reporting Persons) have filed an Amendment No. 2 to Schedule 13G regarding ReShape Lifesciences Inc.
• As of June 30, 2025, the Reporting Persons beneficially own 0% of ReShape Lifesciences Inc.'s Common Stock.
• This represents an aggregate amount of 0.00 shares beneficially owned by each Reporting Person.
• Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and previously held shared voting and dispositive power over the shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 2

Explanation: The complete divestment by institutional investors, reducing their stake to 0%, is a strong negative signal for the company's stock, indicating a lack of confidence or a strategic shift by these investors.

Negatives

• CVI Investments, Inc. and Heights Capital Management, Inc. have reduced their beneficial ownership in ReShape Lifesciences Inc. to 0%.
• This indicates a complete divestment by these institutional investors.

Future Outlook

Not applicable as this filing pertains solely to a change in beneficial ownership by passive investors and does not provide forward-looking statements from the issuer.

Industry Context

This filing reflects a specific institutional investor's decision to exit their position in ReShape Lifesciences Inc. It does not provide broader industry trends or competitive analysis, though a significant investor exit could be perceived negatively within the industry.

Stakeholder Impact

• Shareholders may view the complete divestment by institutional investors as a negative indicator, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Recommendation

The complete divestment by CVI Investments, Inc. and Heights Capital Management, Inc., reducing their beneficial ownership to 0%, signals a significant loss of institutional confidence. This action by a sophisticated investor suggests a negative outlook on the company's prospects or a re-evaluation of its investment thesis, which typically precedes or accompanies downward pressure on the stock price. Investors should consider this a strong bearish signal.

Keywords

ReShape Lifesciences, RSLS, Schedule 13G, Beneficial Ownership, CVI Investments, Heights Capital Management, Divestment, Institutional Investor